- Email: [email protected]
Change and Continuity at the Journal of Substance Abuse Treatment
Change and Continuity at the Journal of Substance Abuse Treatment Hannah K Knudsen PII: DOI: Reference:
S0740-5472(16)30346-4 doi: 10.1016/j.jsat.2016.09.009 SAT 7490
To appear in:
Journal of Substance Abuse Treatment
Received date: Accepted date:
19 September 2016 30 September 2016
Please cite this article as: Knudsen, H.K., Change and Continuity at the Journal of Substance Abuse Treatment, Journal of Substance Abuse Treatment (2016), doi: 10.1016/j.jsat.2016.09.009
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Editorial
T
Change and Continuity at the Journal of Substance Abuse Treatment
RI P
Hannah K. Knudsen
SC
Welcome to a new year of innovative research at the Journal of Substance Abuse Treatment.
NU
This issue marks a transition in the leadership of the journal. After 7 years of leading JSAT, Dr. Mark McGovern has stepped down from serving as JSAT’s Editor-in-Chief, and I am honored to
MA
be assuming that role. When I learned that Mark intended to wrap up his time as Editor, I spent quite a bit of time considering whether I would apply for the position. I reflected upon my own
ED
experiences, beginning with my first manuscript submission more than 13 years ago and the
PT
many times that I reviewed for JSAT. I was fortunate to have the opportunity to learn about the editorial side when Dr. Tom McLellan selected Mark and myself as the two inaugural Editorial
CE
Fellows back in 2006. I remain grateful to Tom for that opportunity—I learned so much from
AC
him about the ethics of publishing and how to balance the sometime conflicting perspectives of reviewers when making an editorial decision. In 2010 when Mark became Editor, I happily accepted his invitation to serve as one of his Associate Editors. I want to thank Mark for that opportunity and for the many, many hours that he has devoted to the success of JSAT. Under this leadership, JSAT has processed a growing number of submissions and has expanded to publishing 12 issues per year. He leaves with a journal impact factor that is on the rise, which is just one of many metrics that shows the trajectory of a journal. Mark has been a significant mentor to me, and I am grateful that he has agreed to continue to serve on JSAT’s Editorial Board. I also want to acknowledge the work of Chantal Lambert-Harris, who has served as
ACCEPTED MANUSCRIPT Managing Editor. Chantal handled many of the activities that are required to move manuscripts through the review process and into publication; her work has been vitally important. Finally,
T
JSAT is fortunate to have a committed Editorial Board, consisting of 48 board members who
RI P
perform many of the manuscript reviews for the nearly 400 submitted articles that JSAT receives
SC
annually.
NU
JSAT has played a significant part of my career, and I profoundly believe in its mission. JSAT’s greatest strength is its interdisciplinary and translational approach to studying the treatment of
MA
substance use disorder (SUD) and its associated conditions. It is one of the premier journals for publishing treatment effectiveness research as well as research on the delivery of treatment
ED
services across a wide range of settings. This dual commitment to effectiveness research and
PT
translational health services research means that JSAT publishes articles that employ a diverse range of methodologies (e.g., experimental, observational, qualitative, economic) and include
CE
varying perspectives, ranging from patients and clinicians to organizations and systems. The
AC
journal’s long history of publishing effectiveness and health services research, particularly studies focused on translating evidence-based interventions into routine practice, preceded the broader move within the US National Institutes of Health (NIH) to promote translational research and implementation science. I believe JSAT was notably ahead of the curve with regard to the rise of translational science, in large part due to the editorial leadership of Tom and Mark.
It is my goal to continue these traditions by publishing the best science that seeks to improve the effectiveness of SUD treatment and to positively impact its delivery by enhancing access and quality in diverse care settings. When I review manuscripts, I find myself focusing more and
ACCEPTED MANUSCRIPT more on the significance and innovation of the work, while continuing to value the rigor of the approach. JSAT will continue to welcome submissions from a range of scientific disciplines that
T
apply diverse methodologies to study the treatment of SUD. I hope that authors submitting
RI P
manuscripts to JSAT will to continue to be responsive to the shifting landscape facing the SUD treatment field, including (but not limited to) the major policy efforts to expand treatment
SC
services into settings that historically have had a limited role. I hope that JSAT can continue to be
NU
nimble in responding to emerging issues facing the field (as it has been with recent Special Issues related to prescription drug abuse, technological treatment interventions, the integration of
MA
treatment into medical care, motivational interviewing, and contingency management). I also hope to expand the number of publications from research teams outside the US so that diverse
PT
ED
approaches to SUD treatment are better understood.
I anticipate that 2017 will be a year of both continuity and change at JSAT. There will be
CE
continuity in that Dr. Peter Friedmann will continue to hold a significant role, now as Deputy
AC
Editor, and Dr. Bettina Hoeppner will continue to serve as our Associate Editor of Biostatistics. We will also be welcoming two new Associate Editors, Dr. Danica Knight from Texas Christian University and Dr. Bryan Garner from RTI International. Both have frequently published their work in JSAT and have reviewed many, many manuscripts for us. Another significant change is that JSAT will have a new Managing Editor who works for our publisher, Elsevier, rather than the Editor’s home institution. We are also continuing to work through the transition to a relatively new online system known as EVISE®. While this new platform will ultimately be beneficial, the transition has been challenging, and all of us on the editorial team are continuing to learn how to navigate it. I hope that we will be able to continue to make progress on one of
ACCEPTED MANUSCRIPT Mark’s major initiatives, namely to reduce the amount of time that manuscripts spend in the review process. Our ability to continue in that endeavor depends on both our editorial team and
RI P
T
the dedication of our reviewers.
As 2017 begins, I am looking forward to reading and reviewing the wide variety of manuscripts
SC
that JSAT receives. There are a number of forces that are coalescing to bring increased attention
NU
to treating individuals with SUD, and JSAT is well positioned to bring science to bear on reducing the significant toll that SUD exerts on individuals and families. To everyone who
MA
accepts our invitations to review and to those who submit their research to JSAT—thank you. We cannot publish JSAT without you, and your work is vitally important to increasing our impact on
AC
CE
PT
ED
the health and well-being of our communities.
S0740-5472(16)30346-4 doi: 10.1016/j.jsat.2016.09.009 SAT 7490
To appear in:
Journal of Substance Abuse Treatment
Received date: Accepted date:
19 September 2016 30 September 2016
Please cite this article as: Knudsen, H.K., Change and Continuity at the Journal of Substance Abuse Treatment, Journal of Substance Abuse Treatment (2016), doi: 10.1016/j.jsat.2016.09.009
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Editorial
T
Change and Continuity at the Journal of Substance Abuse Treatment
RI P
Hannah K. Knudsen
SC
Welcome to a new year of innovative research at the Journal of Substance Abuse Treatment.
NU
This issue marks a transition in the leadership of the journal. After 7 years of leading JSAT, Dr. Mark McGovern has stepped down from serving as JSAT’s Editor-in-Chief, and I am honored to
MA
be assuming that role. When I learned that Mark intended to wrap up his time as Editor, I spent quite a bit of time considering whether I would apply for the position. I reflected upon my own
ED
experiences, beginning with my first manuscript submission more than 13 years ago and the
PT
many times that I reviewed for JSAT. I was fortunate to have the opportunity to learn about the editorial side when Dr. Tom McLellan selected Mark and myself as the two inaugural Editorial
CE
Fellows back in 2006. I remain grateful to Tom for that opportunity—I learned so much from
AC
him about the ethics of publishing and how to balance the sometime conflicting perspectives of reviewers when making an editorial decision. In 2010 when Mark became Editor, I happily accepted his invitation to serve as one of his Associate Editors. I want to thank Mark for that opportunity and for the many, many hours that he has devoted to the success of JSAT. Under this leadership, JSAT has processed a growing number of submissions and has expanded to publishing 12 issues per year. He leaves with a journal impact factor that is on the rise, which is just one of many metrics that shows the trajectory of a journal. Mark has been a significant mentor to me, and I am grateful that he has agreed to continue to serve on JSAT’s Editorial Board. I also want to acknowledge the work of Chantal Lambert-Harris, who has served as
ACCEPTED MANUSCRIPT Managing Editor. Chantal handled many of the activities that are required to move manuscripts through the review process and into publication; her work has been vitally important. Finally,
T
JSAT is fortunate to have a committed Editorial Board, consisting of 48 board members who
RI P
perform many of the manuscript reviews for the nearly 400 submitted articles that JSAT receives
SC
annually.
NU
JSAT has played a significant part of my career, and I profoundly believe in its mission. JSAT’s greatest strength is its interdisciplinary and translational approach to studying the treatment of
MA
substance use disorder (SUD) and its associated conditions. It is one of the premier journals for publishing treatment effectiveness research as well as research on the delivery of treatment
ED
services across a wide range of settings. This dual commitment to effectiveness research and
PT
translational health services research means that JSAT publishes articles that employ a diverse range of methodologies (e.g., experimental, observational, qualitative, economic) and include
CE
varying perspectives, ranging from patients and clinicians to organizations and systems. The
AC
journal’s long history of publishing effectiveness and health services research, particularly studies focused on translating evidence-based interventions into routine practice, preceded the broader move within the US National Institutes of Health (NIH) to promote translational research and implementation science. I believe JSAT was notably ahead of the curve with regard to the rise of translational science, in large part due to the editorial leadership of Tom and Mark.
It is my goal to continue these traditions by publishing the best science that seeks to improve the effectiveness of SUD treatment and to positively impact its delivery by enhancing access and quality in diverse care settings. When I review manuscripts, I find myself focusing more and
ACCEPTED MANUSCRIPT more on the significance and innovation of the work, while continuing to value the rigor of the approach. JSAT will continue to welcome submissions from a range of scientific disciplines that
T
apply diverse methodologies to study the treatment of SUD. I hope that authors submitting
RI P
manuscripts to JSAT will to continue to be responsive to the shifting landscape facing the SUD treatment field, including (but not limited to) the major policy efforts to expand treatment
SC
services into settings that historically have had a limited role. I hope that JSAT can continue to be
NU
nimble in responding to emerging issues facing the field (as it has been with recent Special Issues related to prescription drug abuse, technological treatment interventions, the integration of
MA
treatment into medical care, motivational interviewing, and contingency management). I also hope to expand the number of publications from research teams outside the US so that diverse
PT
ED
approaches to SUD treatment are better understood.
I anticipate that 2017 will be a year of both continuity and change at JSAT. There will be
CE
continuity in that Dr. Peter Friedmann will continue to hold a significant role, now as Deputy
AC
Editor, and Dr. Bettina Hoeppner will continue to serve as our Associate Editor of Biostatistics. We will also be welcoming two new Associate Editors, Dr. Danica Knight from Texas Christian University and Dr. Bryan Garner from RTI International. Both have frequently published their work in JSAT and have reviewed many, many manuscripts for us. Another significant change is that JSAT will have a new Managing Editor who works for our publisher, Elsevier, rather than the Editor’s home institution. We are also continuing to work through the transition to a relatively new online system known as EVISE®. While this new platform will ultimately be beneficial, the transition has been challenging, and all of us on the editorial team are continuing to learn how to navigate it. I hope that we will be able to continue to make progress on one of
ACCEPTED MANUSCRIPT Mark’s major initiatives, namely to reduce the amount of time that manuscripts spend in the review process. Our ability to continue in that endeavor depends on both our editorial team and
RI P
T
the dedication of our reviewers.
As 2017 begins, I am looking forward to reading and reviewing the wide variety of manuscripts
SC
that JSAT receives. There are a number of forces that are coalescing to bring increased attention
NU
to treating individuals with SUD, and JSAT is well positioned to bring science to bear on reducing the significant toll that SUD exerts on individuals and families. To everyone who
MA
accepts our invitations to review and to those who submit their research to JSAT—thank you. We cannot publish JSAT without you, and your work is vitally important to increasing our impact on
AC
CE
PT
ED
the health and well-being of our communities.